Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifevantage (LFVN) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Lifevantage (LFVN) over the last 16 years, with Q4 2025 value amounting to -$396000.0.

  • Lifevantage's Change in Accured Expenses fell 10864.25% to -$396000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$7.3 million, marking a year-over-year decrease of 24217.95%. This contributed to the annual value of $6.0 million for FY2025, which is 353011.36% up from last year.
  • As of Q4 2025, Lifevantage's Change in Accured Expenses stood at -$396000.0, which was down 10864.25% from -$8.1 million recorded in Q3 2025.
  • Lifevantage's Change in Accured Expenses' 5-year high stood at $4.6 million during Q4 2024, with a 5-year trough of -$8.1 million in Q3 2025.
  • In the last 5 years, Lifevantage's Change in Accured Expenses had a median value of $283000.0 in 2021 and averaged -$97800.0.
  • As far as peak fluctuations go, Lifevantage's Change in Accured Expenses soared by 87792.87% in 2024, and later plummeted by 405512.2% in 2025.
  • Over the past 5 years, Lifevantage's Change in Accured Expenses (Quarter) stood at $85000.0 in 2021, then skyrocketed by 358.82% to $390000.0 in 2022, then tumbled by 251.03% to -$589000.0 in 2023, then skyrocketed by 877.93% to $4.6 million in 2024, then tumbled by 108.64% to -$396000.0 in 2025.
  • Its Change in Accured Expenses stands at -$396000.0 for Q4 2025, versus -$8.1 million for Q3 2025 and -$2.1 million for Q2 2025.